SCHEMBL19649201

SCHEMBL19649201

Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C1CCCN([S+]([O-])C(F)(F)F)C1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 20/20 0.70
▸ LYN P07948 3/20 0.70
▸ LCK P06239 3/20 0.70
▸ EGFR P00533 4/20 0.64
▸ TEC P42680 3/20 0.64
▸ BMX P51813 3/20 0.64
▸ ITK Q08881 3/20 0.64
▸ TXK P42681 2/20 0.64
▸ FGFR2 P21802 2/20 0.64
▸ NUDT14 O95848 2/20 0.64
▸ NUDT5 Q9UKK9 2/20 0.64
▸ BLK P51451 2/20 0.64
▸ RIPK2 O43353 1/20 0.64
▸ NR1I2 O75469 1/20 0.64
▸ SLC22A3 O75751 1/20 0.64
▸ LATS1 O95835 1/20 0.64
▸ ABL1 P00519 1/20 0.64
▸ ERBB2 P04626 1/20 0.64
▸ FYN P06241 1/20 0.64
▸ PGR P06401 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10189862 0.88 BTK (0.72) BTKLYNLCKEGFRTEC
SCHEMBL18667291 0.88 BTK (0.72) BTKLYNLCKEGFRTEC
SCHEMBL2730415 0.88 BTK (0.69) BTKLYNLCKEGFRTEC
SCHEMBL18608117 0.85 BTK (0.80) BTKLYNLCKEGFRTEC
SCHEMBL21898176 0.85 BTK (0.80) BTKLYNLCKEGFRTEC
SCHEMBL25068925 0.84 BTK (0.80) BTKLYNLCKEGFRTEC
SCHEMBL22737178 0.84 BTK (0.80) BTKLYNLCKEGFRTEC
SCHEMBL18235474 0.84 BTK (0.78) BTKLYNLCKEGFRTEC
SCHEMBL19230350 0.84 BTK (0.78) BTKLYNLCKEGFRTEC
SCHEMBL16075638 0.84 BTK (0.80) BTKLYNLCKEGFRTEC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3248979-A1 NOVEL INHIBITOR OF FLT3 KINASE AND USE THEREOF Hefei Institutes of Physical Sicence, Chinese Academy of Sciences (CN) 2017-11-29 — — EP disclosed
Send feedback